应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02142 和铂医药-B
休市中 07-11 16:08:03
7.740
-0.220
-2.76%
最高
8.200
最低
7.720
成交量
564.60万
今开
8.200
昨收
7.960
日振幅
6.03%
总市值
63.93亿
流通市值
63.93亿
总股本
8.26亿
成交额
4,438万
换手率
0.68%
流通股本
8.26亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
和铂医药-B(02142)7月11日耗资约232.8万港元回购30万股
智通财经 · 07-11 10:58
和铂医药-B(02142)7月11日耗资约232.8万港元回购30万股
每日卖空追踪 | 和铂医药-B 07月11日卖空量成交20.3万股,卖空比例为3.6%
市场透视 · 07-11 08:30
每日卖空追踪 | 和铂医药-B 07月11日卖空量成交20.3万股,卖空比例为3.6%
和铂医药-B07月11日主力净流出2.4万元 散户资金买入
市场透视 · 07-11 08:16
和铂医药-B07月11日主力净流出2.4万元 散户资金买入
和铂医药-B07月10日主力净流入161.8万元 散户资金抛售
市场透视 · 07-10 08:15
和铂医药-B07月10日主力净流入161.8万元 散户资金抛售
【券商聚焦】招商证券首予和铂医药(02142) “强烈推荐”评级 看好其抗体平台的潜力
金吾财讯 · 07-10 06:52
【券商聚焦】招商证券首予和铂医药(02142) “强烈推荐”评级 看好其抗体平台的潜力
和铂医药-B(02142):恩凯赛药已完成A+++轮融资 融资近1亿元
智通财经 · 07-09 15:00
和铂医药-B(02142):恩凯赛药已完成A+++轮融资 融资近1亿元
2025上半年BD王者榜:国产创新药的国际突围
CPHI制药在线 · 07-09 09:45
2025上半年BD王者榜:国产创新药的国际突围
每日卖空追踪 | 和铂医药-B 07月09日卖空量成交74.9万股,卖空比例为10.77%
市场透视 · 07-09 08:30
每日卖空追踪 | 和铂医药-B 07月09日卖空量成交74.9万股,卖空比例为10.77%
过去十年,中国在这个领域首次超过美国
中国新闻周刊 · 07-08
过去十年,中国在这个领域首次超过美国
和铂医药-B07月08日遭主力抛售182.7万元
市场透视 · 07-08
和铂医药-B07月08日遭主力抛售182.7万元
和铂医药-B(02142)7月7日斥资81.83万港元回购10万股
智通财经 · 07-07
和铂医药-B(02142)7月7日斥资81.83万港元回购10万股
每日卖空追踪 | 和铂医药-B 07月07日卖空量成交34万股,卖空比例为9.05%
市场透视 · 07-07
每日卖空追踪 | 和铂医药-B 07月07日卖空量成交34万股,卖空比例为9.05%
和铂医药-B07月07日遭主力抛售59.5万元
市场透视 · 07-07
和铂医药-B07月07日遭主力抛售59.5万元
过去十年,中国在这个领域首次超过美国
中国新闻周刊 · 07-05
过去十年,中国在这个领域首次超过美国
每日卖空追踪 | 和铂医药-B 07月04日卖空量成交55.9万股,卖空比例为7.65%
市场透视 · 07-04
每日卖空追踪 | 和铂医药-B 07月04日卖空量成交55.9万股,卖空比例为7.65%
从“减重效率”到“减重质量”,GLP-1“战争”下半场逻辑剧变
医曜 · 07-03
从“减重效率”到“减重质量”,GLP-1“战争”下半场逻辑剧变
和铂医药-B07月03日遭主力抛售59.3万元
市场透视 · 07-03
和铂医药-B07月03日遭主力抛售59.3万元
每日卖空追踪 | 和铂医药-B 07月02日卖空量成交89万股,卖空比例为11.76%
市场透视 · 07-02
每日卖空追踪 | 和铂医药-B 07月02日卖空量成交89万股,卖空比例为11.76%
和铂医药-B(02142)授出346.5万份购股权
智通财经 · 07-02
和铂医药-B(02142)授出346.5万份购股权
自免 TCE 风起云涌,中国 Biotech 差异化布局领跑全球
医麦客 · 06-30
自免 TCE 风起云涌,中国 Biotech 差异化布局领跑全球
加载更多
公司概况
公司名称:
和铂医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
和铂医药控股有限公司是一家主要从事肿瘤免疫学及免疫性疾病领域的创新疗法开发业务的投资控股公司。该公司的产品包括HBM9161, HBM4003, HBM7008 and HBM1020。其中,巴托利单抗(HBM9161)主要用于免疫性血小板减少症、甲状腺相关性眼病、重症肌无力、视神经脊髓炎谱系疾病等. 特那西普(HBM9036)主要用于干眼病。此外,该公司还研究和开发肿瘤免疫产品管线,包括内部开发的新一代肿瘤免疫资产,针对治疗免疫沙漠型、免疫排斥型及炎症型肿瘤。该公司拥有Harbour Mice平台,该平台能够产生经典的双重链双轻链(H2L2)形式及仅重链(HCAb)形式的全人源单克隆抗体。
发行价格:
--
{"stockData":{"symbol":"02142","market":"HK","secType":"STK","nameCN":"和铂医药-B","latestPrice":7.74,"timestamp":1752221283030,"preClose":7.96,"halted":0,"volume":5646000,"delay":0,"floatShares":826000000,"shares":826000000,"eps":0.028384605119590556,"marketStatus":"休市中","change":-0.22,"latestTime":"07-11 16:08:03","open":8.2,"high":8.2,"low":7.72,"amount":44375095,"amplitude":0.060302,"askPrice":7.74,"askSize":18000,"bidPrice":7.73,"bidSize":162000,"shortable":3,"etf":0,"ttmEps":0.028384605119590556,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":7,"adr":0,"listingDate":1607529600000,"exchange":"SEHK","adjPreClose":7.96,"openAndCloseTimeList":[[1752197400000,1752206400000],[1752210000000,1752220800000]],"volumeRatio":0.9740394170305464,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02142","defaultTab":"news","newsList":[{"id":"2550937251","title":"和铂医药-B(02142)7月11日耗资约232.8万港元回购30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2550937251","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550937251?lang=zh_cn&edition=full","pubTime":"2025-07-11 18:58","pubTimestamp":1752231535,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和铂医药-B(02142)公布,2025年7月11日耗资约232.8万港元回购30万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1316865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","02142","BK1574"],"gpt_icon":0},{"id":"2550093109","title":"每日卖空追踪 | 和铂医药-B 07月11日卖空量成交20.3万股,卖空比例为3.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550093109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550093109?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:30","pubTimestamp":1752222628,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间07月11日,跌2.76%,卖空量成交20.3万股%,较上一交易日减少74.27%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172451a6a37de2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172451a6a37de2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","02142","BK1574"],"gpt_icon":0},{"id":"2550363109","title":"和铂医药-B07月11日主力净流出2.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2550363109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550363109?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:16","pubTimestamp":1752221768,"startTime":"0","endTime":"0","summary":"07月11日, 和铂医药-B股价跌2.76%,报收7.74元,成交金额4437.5万元,换手率0.68%,振幅6.03%,量比0.97。和铂医药-B今日主力资金净流出2.4万元,上一交易日主力净流入161.8万元。该股近5个交易日下跌7.87%,主力资金累计净流出145.0万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出433.4万元,其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171240a444776a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171240a444776a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","02142","BK1574"],"gpt_icon":0},{"id":"2550617390","title":"和铂医药-B07月10日主力净流入161.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2550617390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550617390?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:15","pubTimestamp":1752135346,"startTime":"0","endTime":"0","summary":"07月10日, 和铂医药-B股价涨0.51%,报收7.96元,成交金额3156.1万元,换手率0.48%,振幅3.91%,量比0.62。和铂医药-B今日主力资金净流入161.8万元,上一交易日主力净流出62.2万元。该股近5个交易日下跌5.80%,主力资金累计净流出617.0万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出303.6万元,其中净流出天数为14日。该股主力净额占比0.02%,港股市场排名355/2673。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165846a6a13a55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165846a6a13a55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02142","BK1574","BK1583"],"gpt_icon":0},{"id":"2550613019","title":"【券商聚焦】招商证券首予和铂医药(02142) “强烈推荐”评级 看好其抗体平台的潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2550613019","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550613019?lang=zh_cn&edition=full","pubTime":"2025-07-10 14:52","pubTimestamp":1752130354,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招商证券研报指,2024-2028年为跨国药企专利悬崖的高峰期,叠加国际上对药价管控愈发严格的趋势,无论是跨国药企,抑或是海外Biotech公司,对优质创新药项目均存在广泛的需求。和铂医药定位于全球生物医药研发引擎,历经9年时间发展,早期研发项目已经与全球大型制药公司、领先创新药公司以及 AI 药研公司展开广泛、紧密的战略合作。疾病领域布局肿瘤、代谢、自身免疫等。首次覆盖,给予 “强烈推荐”投资评级。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1962010","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06099","02142"],"gpt_icon":0},{"id":"2550373659","title":"和铂医药-B(02142):恩凯赛药已完成A+++轮融资 融资近1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550373659","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550373659?lang=zh_cn&edition=full","pubTime":"2025-07-09 23:00","pubTimestamp":1752073251,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和铂医药-B 公布,公司所投资的公司上海恩凯细胞技术有限公司近日已完成A+++轮融资,本轮融资由多名投资者参与,融资近人民币1亿元。据悉,恩凯赛药是一家生物科技公司,专注于NK细胞疗法创新技术的研发。于2021年6月,公司通过其附属公司和铂医药(上海)科技发展有限公司作为联合创始人向恩凯赛药投资。截至2024年12月31日,公司通过和铂医药上海持有恩凯赛药总股权10.90%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1315964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2550313156","title":"2025上半年BD王者榜:国产创新药的国际突围","url":"https://stock-news.laohu8.com/highlight/detail?id=2550313156","media":"CPHI制药在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550313156?lang=zh_cn&edition=full","pubTime":"2025-07-09 17:45","pubTimestamp":1752054334,"startTime":"0","endTime":"0","summary":"二、技术出海先锋:和铂医药在2025年上半年的生物医药BD交易市场中,和铂医药同样表现得极为亮眼,成为了授权合作数量方面的佼佼者,凭借7项授权交易独占鳌头。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709190104a69f4bdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709190104a69f4bdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02696","688336","688177","06978","BK1583","BK1161","BK1574","BK1593","01530","02142"],"gpt_icon":0},{"id":"2550638100","title":"每日卖空追踪 | 和铂医药-B 07月09日卖空量成交74.9万股,卖空比例为10.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550638100","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550638100?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:30","pubTimestamp":1752049828,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间07月09日,涨0.13%,卖空量成交74.9万股%,较上一交易日减少22.86%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172347a44004f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172347a44004f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2549610548","title":"过去十年,中国在这个领域首次超过美国","url":"https://stock-news.laohu8.com/highlight/detail?id=2549610548","media":"中国新闻周刊","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549610548?lang=zh_cn&edition=full","pubTime":"2025-07-08 17:30","pubTimestamp":1751967015,"startTime":"0","endTime":"0","summary":"7月3日,迪哲医药公告称,舒沃哲的新药上市申请正式获得美国食品药品监督管理局批准。据方正证券统计,2025年上半年,创新药对外授权首付款已超过25亿美元,交易总金额近500亿美元,与去年全年水平几乎相仿。今年3月,阿斯利康与和铂医药达成了一项全球战略合作。截至目前,和铂医药已完成17次BD出海交易,成为中国BD出海交易最多的药企。2015—2024年首次进入临床的创新药中,中国企业原研药数量超过美国,排名第一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708173133a69cde63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708173133a69cde63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06978","BK1191","01276","02142","BK1574","BK1583"],"gpt_icon":0},{"id":"2549510566","title":"和铂医药-B07月08日遭主力抛售182.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549510566","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549510566?lang=zh_cn&edition=full","pubTime":"2025-07-08 16:16","pubTimestamp":1751962563,"startTime":"0","endTime":"0","summary":"07月08日, 和铂医药-B股价跌3.06%,报收7.91元,成交金额5593.3万元,换手率0.84%,振幅5.76%,量比0.67。和铂医药-B今日主力资金净流出182.7万元,连续7日净流出,上一交易日主力净流出59.5万元。该股近5个交易日下跌6.72%,主力资金累计净流出831.5万元;近20日主力资金累计净流入2414.6万元,其中净流入天数为6日。该股主力净额占比0.03%,港股市场排名2510/2669。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708170359a69ccdaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708170359a69ccdaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1583","BK1161","BK1574"],"gpt_icon":1},{"id":"2549537481","title":"和铂医药-B(02142)7月7日斥资81.83万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2549537481","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549537481?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:07","pubTimestamp":1751893669,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和铂医药-B(02142)发布公告,于2025年7月7日,该公司斥资81.83万港元回购10万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314842.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","BK1583","02142"],"gpt_icon":0},{"id":"2549580085","title":"每日卖空追踪 | 和铂医药-B 07月07日卖空量成交34万股,卖空比例为9.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549580085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549580085?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:30","pubTimestamp":1751877028,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间07月07日,跌2.74%,卖空量成交34万股%,较上一交易日减少60.28%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171937a43b8344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171937a43b8344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02142","BK1583","BK1574"],"gpt_icon":0},{"id":"2549825315","title":"和铂医药-B07月07日遭主力抛售59.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549825315","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549825315?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:15","pubTimestamp":1751876144,"startTime":"0","endTime":"0","summary":"07月07日, 和铂医药-B股价跌2.74%,报收8.16元,成交金额3080.9万元,换手率0.45%,振幅3.10%,量比0.34。和铂医药-B今日主力资金净流出59.5万元,连续6日净流出,上一交易日主力净流出474.4万元。近一年数据显示,该股主力连续6日净流出后,次日下跌概率为33.33%,平均跌幅为4.10%。该股近5个交易日下跌0.85%,主力资金累计净流出693.5万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入2330.0万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707165747a43b751a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707165747a43b751a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2549131783","title":"过去十年,中国在这个领域首次超过美国","url":"https://stock-news.laohu8.com/highlight/detail?id=2549131783","media":"中国新闻周刊","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549131783?lang=zh_cn&edition=full","pubTime":"2025-07-05 12:31","pubTimestamp":1751689875,"startTime":"0","endTime":"0","summary":"7月3日,迪哲医药公告称,舒沃哲的新药上市申请正式获得美国食品药品监督管理局批准。据方正证券统计,2025年上半年,创新药对外授权首付款已超过25亿美元,交易总金额近500亿美元,与去年全年水平几乎相仿。今年3月,阿斯利康与和铂医药达成了一项全球战略合作。截至目前,和铂医药已完成17次BD出海交易,成为中国BD出海交易最多的药企。2015—2024年首次进入临床的创新药中,中国企业原研药数量超过美国,排名第一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250705124000a72fe715&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250705124000a72fe715&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1152091168.USD","LU1226287792.SGD","BK1583","688192","LU1807302812.USD","BK1191","LU0140636845.USD","BK1515","IE00B5MMRT66.SGD","LU0067412154.USD","IE0008368742.USD","LU1008478684.HKD","LU1993786604.SGD","IE0008369823.USD","BK1521","LU1226288253.USD","LU1226287875.USD","BK1574","01530","02142","06978","SG9999004220.SGD","01093","BK1161","LU1152091754.HKD","LU0315179316.USD","LU0501845795.SGD","600276","IE00BZ08YS42.EUR","LU1226288170.HKD","IE00B543WZ88.USD","IE00B031HY20.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU0072913022.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU1226287529.USD","LU1960683339.HKD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2548536224","title":"每日卖空追踪 | 和铂医药-B 07月04日卖空量成交55.9万股,卖空比例为7.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548536224","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548536224?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:30","pubTimestamp":1751617829,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间07月04日,跌0.71%,卖空量成交55.9万股%,较上一交易日减少52.79%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704172200a72e88f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704172200a72e88f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02142","BK1574","BK1583"],"gpt_icon":0},{"id":"2548733304","title":"从“减重效率”到“减重质量”,GLP-1“战争”下半场逻辑剧变","url":"https://stock-news.laohu8.com/highlight/detail?id=2548733304","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548733304?lang=zh_cn&edition=full","pubTime":"2025-07-04 07:36","pubTimestamp":1751585809,"startTime":"0","endTime":"0","summary":"司美格鲁肽与替尔泊肽均成为“药王级”产品,似乎GLP-1已然兑现了市场对它的期待。两大行业巨头礼来与诺和诺德,看似稳坐云端宝座,实则危机四伏,各路豪强对GLP-1下半场虎视眈眈。GLP-1争夺战并未结束,即将开启的下半场或将出现更大规模的拼杀。根据辉瑞预测,2030年GLP-1市场的规模将达到约900亿美元,口服产品预计到2030年将占据GLP-1市场约30%的份额,主要原因是患者对口服制剂的偏好较高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704074156a72d7aa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704074156a72d7aa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMGN","06618","BK1589","NVO","01801","02696","06160","02359","02096","01877","LLY","03692","06855","BK1585","00853","01952","02142","02269","BK1583","600276","BK1100"],"gpt_icon":1},{"id":"2548803564","title":"和铂医药-B07月03日遭主力抛售59.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548803564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548803564?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:16","pubTimestamp":1751530561,"startTime":"0","endTime":"0","summary":"07月03日, 和铂医药-B股价跌0.12%,报收8.45元,成交金额5972.8万元,换手率0.86%,振幅5.67%,量比0.64。和铂医药-B今日主力资金净流出59.3万元,连续4日净流出,上一交易日主力净流出55.6万元。近一年数据显示,该股主力连续4日净流出后,次日下跌概率为33.33%,平均跌幅为1.94%。该股近5个交易日下跌1.97%,主力资金累计净流出454.0万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流入2047.9万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703171048a4cd007d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703171048a4cd007d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","02142"],"gpt_icon":0},{"id":"2548867915","title":"每日卖空追踪 | 和铂医药-B 07月02日卖空量成交89万股,卖空比例为11.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548867915","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548867915?lang=zh_cn&edition=full","pubTime":"2025-07-02 16:30","pubTimestamp":1751445029,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间07月02日,跌0.24%,卖空量成交89万股%,较上一交易日减少29.31%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702172119a72a4923&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702172119a72a4923&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2548393508","title":"和铂医药-B(02142)授出346.5万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2548393508","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548393508?lang=zh_cn&edition=full","pubTime":"2025-07-02 08:27","pubTimestamp":1751416032,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和铂医药-B(02142)发布公告,于2025年6月30日,根据公司股东于2020年11月23日采纳的购股权计划,公司向合资格参与者授出346.5万份购股权,惟须待承授人接纳后生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1312802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","BK1583","02142"],"gpt_icon":0},{"id":"2548046015","title":"自免 TCE 风起云涌,中国 Biotech 差异化布局领跑全球","url":"https://stock-news.laohu8.com/highlight/detail?id=2548046015","media":"医麦客","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548046015?lang=zh_cn&edition=full","pubTime":"2025-07-01 07:20","pubTimestamp":1751325625,"startTime":"0","endTime":"0","summary":"公开数据显示,目前全球已有约 10 款 TCE 疗法获批上市,主要覆盖血液瘤与实体瘤两大领域,靶点包括 CD19、CD20、BCMA 和 GPRC5D 等。国产自免 TCE 出海潮四家 CD3/BCMA 各有千秋近一年来,MNC 在自免领域的管线争夺趋于白热化。此前,PIT565 已在国内获批临床,拟用于治疗 B 细胞恶性肿瘤。目前,PIT565 针对 B 细胞恶性肿瘤和系统性红斑狼疮两种适应症均处于 1 期临床。CC312是惠和生物基于其新一代共刺激信号 TCE 平台 TriTETM自主研发的CD19/CD3/CD28 三抗,也是全球首个获批系统性","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701072710a4c779eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701072710a4c779eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688443","02142","BK0239","688506","02162"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0775},{"period":"1month","weight":-0.1448},{"period":"3month","weight":0.0825},{"period":"6month","weight":2.2116},{"period":"1year","weight":4.8195},{"period":"ytd","weight":3.1613}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":-0.0093},{"period":"3month","weight":0.1542},{"period":"6month","weight":0.2662},{"period":"1year","weight":0.3537},{"period":"ytd","weight":0.2034}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和铂医药控股有限公司是一家主要从事肿瘤免疫学及免疫性疾病领域的创新疗法开发业务的投资控股公司。该公司的产品包括HBM9161, HBM4003, HBM7008 and HBM1020。其中,巴托利单抗(HBM9161)主要用于免疫性血小板减少症、甲状腺相关性眼病、重症肌无力、视神经脊髓炎谱系疾病等. 特那西普(HBM9036)主要用于干眼病。此外,该公司还研究和开发肿瘤免疫产品管线,包括内部开发的新一代肿瘤免疫资产,针对治疗免疫沙漠型、免疫排斥型及炎症型肿瘤。该公司拥有Harbour Mice平台,该平台能够产生经典的双重链双轻链(H2L2)形式及仅重链(HCAb)形式的全人源单克隆抗体。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.104328},{"month":2,"riseRate":0.2,"avgChangeRate":-0.004171},{"month":3,"riseRate":0.4,"avgChangeRate":0.046232},{"month":4,"riseRate":0.4,"avgChangeRate":0.013317},{"month":5,"riseRate":0.6,"avgChangeRate":0.040454},{"month":6,"riseRate":0.2,"avgChangeRate":-0.066065},{"month":7,"riseRate":0.2,"avgChangeRate":-0.008794},{"month":8,"riseRate":0,"avgChangeRate":-0.134459},{"month":9,"riseRate":0.25,"avgChangeRate":-0.098643},{"month":10,"riseRate":0,"avgChangeRate":-0.190485},{"month":11,"riseRate":0.75,"avgChangeRate":0.322177},{"month":12,"riseRate":0.75,"avgChangeRate":0.358142}],"exchange":"SEHK","name":"和铂医药-B","nameEN":"HBM HOLDINGS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和铂医药-B,02142,和铂医药-B股票,和铂医药-B股票老虎,和铂医药-B股票老虎国际,和铂医药-B行情,和铂医药-B股票行情,和铂医药-B股价,和铂医药-B股市,和铂医药-B股票价格,和铂医药-B股票交易,和铂医药-B股票购买,和铂医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}